# CANOPY-A (NCT03447769)

> Brief Title: Study of Efficacy and Safety of Canakinumab as Adjuvant Therapy in Adult Subjects With Stages AJCC/UICC v. 8 II-IIIA and IIIB (T>5cm N2) Completely Resected Non-small Cell Lung Cancer Acronym: CANOPY-A

No report yet. It can be ordered.

- Drugs tested: canakinumab

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT03447769
- Phase: PHASE3
- Status: TERMINATED
- Sponsor: Novartis Pharmaceuticals
- Conditions: Non-Small Cell Lung Cancer
- Interventions: Canakinumab; Placebo
- Enrollment: 1382
- Primary outcome: Disease Free Survival (DFS) by Local Investigator

## Indexed commentary on CANOPY-A so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- X threads: 7
- YouTube: 1

## Order

Focused, $750, price fixed at order: https://www.erudio.com/contact?report=canopy-a-nct03447769

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT03447769", "email": "<work email>"}; the inbox owner confirms by the emailed link.